Basic Materials / Specialty ChemicalsIstanbul
$19.68
+0.35 (+1.81%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $220.5M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.4B
P/E
57.9x
↑EV/EBITDA
42.3x
↑ROE
1.7%
↑Gross Margin
12.8%
↓Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.8%
FCF CAGR
—
FCF margin
-8.0%
FCF / Net income
-1.81x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $542.6M · net income $23.9M · FCF $-43.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $542.6M | $542.6M | $545.1M | $519.2M | $388.0M |
| Net Income | $23.9M | $23.9M | $-70.4M | $22.1M | $32.6M |
| EBITDA | $55.5M | $55.5M | $214.8M | $106.2M | $105.6M |
| EPS | 0.20 | 0.20 | -0.59 | 0.14 | 0.27 |
| Gross Margin | 12.8% | 12.8% | 18.0% | 14.5% | 19.0% |
| Operating Margin | 1.6% | 1.6% | 6.7% | 5.4% | 18.4% |
| Net Margin | 4.4% | 4.4% | -12.9% | 4.3% | 8.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 0.09 | 0.22 | 0.26 |
| Current Ratio | 3.33 | 3.33 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-43.2M | $-43.2M | $296.4M | $220.5M | $-158.3M |
| Returns | |||||
| ROE | 1.7% | 1.7% | -5.2% | 2.0% | 5.0% |
| Valuation | |||||
| P/E | 57.88 | 57.88 | — | 98.36 | 22.66 |
| EV/EBITDA | 42.32 | 42.32 | 16.12 | 16.76 | 7.82 |
| P/B | 1.70 | 1.70 | 2.57 | 1.51 | 1.13 |
| Growth & Yield | |||||
| Revenue Growth | -0.4% | -0.4% | 5.0% | 33.8% | — |
| EPS Growth | 133.9% | 133.9% | -521.4% | -48.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
105.9%
EPS terminal req.
$1.75
Spread vs growth
28.0%
5Y implied EPS CAGR
60.2%
EPS terminal req.
$2.11
Spread vs growth
73.7%
10Y implied EPS CAGR
32.8%
EPS terminal req.
$3.40
Spread vs growth
101.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+5.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.59 → 0.20
Residual
+5.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.